Elite Pharmaceuticals Inc
ELTP· OTC
Released Nov 9, 2017, after the close
10-Q filed Nov 9, 2017, 40 days after period end · 0001144204-17-057793
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $1.62M | $2.69M | $2.95M | $1.26M |
| Net Income | $1.82M | $4.24M | -$1.68M | $6.25M |
| EPS Diluted |
Elite Pharmaceuticals Inc · CIK 1053369 · Engraved from SEC EDGAR
| $0.00 |
| $0.00 |
| -$0.01 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.